Study: NCT01998035

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RomiDEPsin 10 MG/M2
Description: Romidepsin is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. Romidepsin is classified as a Histone Deacetylase Inhibitor.~Dose escalation (10 mg/m2)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RomiDEPsin 10 MG/M2
Description: Romidepsin is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. Romidepsin is classified as a Histone Deacetylase Inhibitor.~Dose escalation (10 mg/m2)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RomiDEPsin 10 MG/M2
Description: Romidepsin is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. Romidepsin is classified as a Histone Deacetylase Inhibitor.~Dose escalation (10 mg/m2)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RomiDEPsin 10 MG/M2
Description: Romidepsin is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. Romidepsin is classified as a Histone Deacetylase Inhibitor.~Dose escalation (10 mg/m2)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral 5-Azacitidine 100 MG
Description: A pyrimidine nucleoside analogue of cytidine with antineoplastic activity.~Dose escalation (100 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral 5-Azacitidine 100 MG
Description: A pyrimidine nucleoside analogue of cytidine with antineoplastic activity.~Dose escalation (100 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romidepsin 14 MG/M2
Description: Romidepsin is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. Romidepsin is classified as a Histone Deacetylase Inhibitor.~Dose escalation (14 mg/m2)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romidepsin 14 MG/M2
Description: Romidepsin is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. Romidepsin is classified as a Histone Deacetylase Inhibitor.~Dose escalation (14 mg/m2)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romidepsin 14 MG/M2
Description: Romidepsin is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. Romidepsin is classified as a Histone Deacetylase Inhibitor.~Dose escalation (14 mg/m2)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral 5-Azacitidine 200 MG
Description: A pyrimidine nucleoside analogue of cytidine with antineoplastic activity.~Dose escalation (200 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral 5-Azacitidine 300 MG
Description: A pyrimidine nucleoside analogue of cytidine with antineoplastic activity.~Dose escalation (300 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral 5-Azacitidine 300 MG
Description: A pyrimidine nucleoside analogue of cytidine with antineoplastic activity.~Dose escalation (300 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral 5-Azacitidine 300 MG
Description: A pyrimidine nucleoside analogue of cytidine with antineoplastic activity.~Dose escalation (300 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral 5-Azacitidine 300 MG
Description: A pyrimidine nucleoside analogue of cytidine with antineoplastic activity.~Dose escalation (300 mg)